Skip to main content
Log in

DCD Liver Transplant: a Meta-review of the Evidence and Current Optimization Strategies

  • Liver Transplantation (D Mulligan, Section Editor)
  • Published:
Current Transplantation Reports Aims and scope Submit manuscript

Abstract

Purpose

In the current era of liver transplantation (LT), there is a large discrepancy between waiting list demand and organ donor availability. Increased utilization of donation after circulatory death (DCD) donors continues to expand the donor pool and improve access; however, concerns regarding recipient outcomes have limited wider adoption of these donor livers. This review will describe the current evidence regarding recipient outcomes and strategies that may help to optimize them.

Recent Findings

Historical outcomes of DCD LT are somewhat inferior to the DBD LT, yet new emerging evidence suggests that this outcome disparity may only be marginal at most; however, ischemic cholangiopathy remains a concern. Ideal donor selection criteria and optimizing recipient operative times appear to mitigate some of this risk. Extracorporeal membrane oxygenation (ECMO), hypothermic machine perfusion (HMP), and normothermic machine perfusion (NMP) are promising strategies to further improve graft resilience and performance.

Summary

Cardiac death donors continue to expand the donor pool but may carry an increased risk of biliary complications. Graft reconditioning techniques, donor selection, and recipient optimization appear to mitigate this risk; however, these strategies need further investigation before generalized adoption.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. Asano T. Marginal donors: current and future status. New York: Springer; 2014.

    Book  Google Scholar 

  2. Steinbrook R. Organ donation after cardiac death. N Engl J Med. 2007;357(3):209–13.

    Article  CAS  PubMed  Google Scholar 

  3. Reich DJ, Hong JC. Current status of donation after cardiac death liver transplantation. Curr Opin Organ Transplant. 2010;15(3):316–21.

    Article  PubMed  Google Scholar 

  4. Halpern SD, Barnes B, Hasz RD, Abt PL. Estimated supply of organ donors after circulatory determination of death: a population-based cohort study. JAMA. 2010;304(23):2592–4.

    Article  CAS  PubMed  Google Scholar 

  5. Abt PL, Mange KC, Olthoff KM, Markmann JF, Reddy KR, Shaked A. Allograft survival following adult-to-adult living donor liver transplantation. Am J Transplant. 2004;4(8):1302–7.

    Article  PubMed  Google Scholar 

  6. Foley DP, Fernandez LA, Leverson G, Chin LT, Krieger N, Cooper JT, et al. Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg. 2005;242(5):724–31.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Fung JJ, Eghtesad B, Patel-Tom K. Using livers from donation after cardiac death donors—a proposal to protect the true Achilles heel. Liver Transpl. 2007;13(12):1633–6.

    Article  PubMed  Google Scholar 

  8. Biggins SW, Gralla J, Dodge JL, Bambha KM, Tong S, Barón AE, et al. Survival benefit of repeat liver transplantation in the United States: a serial MELD analysis by hepatitis C status and donor risk index. Am J Transplant. 2014;14(11):2588–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Dubbeld J, Hoekstra H, Farid W, Ringers J, Porte RJ, Metselaar HJ, et al. Similar liver transplantation survival with selected cardiac death donors and brain death donors. Br J Surg. 2010;97(5):744–53.

    Article  CAS  PubMed  Google Scholar 

  10. Jay C, Ladner D, Wang E, Lyuksemburg V, Kang R, Chang Y, et al. A comprehensive risk assessment of mortality following donation after cardiac death liver transplant—an analysis of the national registry. J Hepatol. 2011;55(4):808–13.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Orman ES, Mayorga ME, Wheeler SB, Townsley RM, Toro-Diaz HH, Hayashi PH, et al. Declining liver graft quality threatens the future of liver transplantation in the United States. Liver Transpl. 2015;21(8):1040–50.

    Article  PubMed  PubMed Central  Google Scholar 

  12. •• Croome KP, et al. Improving national results in liver transplantation using grafts from donation after cardiac death donors. Transplantation. 2016;100(12):2640–7. Utilitzing UNOS data, the authors show DCD era effects resulting in improved graft survival as a function of better donor selection and recipient mangement. This illustrates how DCD outcomes have improved with an increased national expereince

    Article  CAS  PubMed  Google Scholar 

  13. Tun Abraham, M., et al., Is there a learning curve in donation after cardiac death liver transplant: a Canadian single-centre experience. In: Congress of the International Hepato-Prancreato-Biliary Association. 2016: Sao Paulo, Brazil.

  14. UNOS. The role of the OPTN in the evolving practice of donation after cardiac death. UNOS. 2007.

  15. Dominguez-Gil B, et al. Current situation of donation after circulatory death in European countries. Transpl Int. 2011;24(7):676–86.

    Article  PubMed  Google Scholar 

  16. Rogers WA, de Lacey S, Avery JC. Donation after cardiac death: community views about ‘decent’ intervals. Am J Transplant. 2011;11(3):583–90.

    Article  CAS  PubMed  Google Scholar 

  17. Wind J, Faut M, van Smaalen TC, van Heurn ELW. Variability in protocols on donation after circulatory death in Europe. Crit Care. 2013;17(5):R217.

    Article  PubMed  PubMed Central  Google Scholar 

  18. NHS. Reports from the UK Health Departments. 2017, National Health Service.

  19. Wilsher, K., France introduces opt-out policy on organ donation. In: The Guardian. 2017.

  20. Blasi A, Hessheimer AJ, Beltrán J, Pereira A, Fernández J, Balust J, et al. Liver transplant from unexpected donation after circulatory determination of death donors: a challenge in perioperative management. Am J Transplant. 2016;16(6):1901–8.

    Article  CAS  PubMed  Google Scholar 

  21. Northup PG, Intagliata NM, Shah NL, Pelletier SJ, Berg CL, Argo CK. Excess mortality on the liver transplant waiting list: unintended policy consequences and model for end-stage liver disease (MELD) inflation. Hepatology. 2015;61(1):285–91.

    Article  PubMed  Google Scholar 

  22. Savier E, Dondero F, Vibert E, Eyraud D, Brisson H, Riou B, et al. First experience of liver transplantation with type 2 donation after cardiac death in France. Liver Transpl. 2015;21(5):631–43.

    Article  PubMed  Google Scholar 

  23. Foley DP, Fernandez LA, Leverson G, Anderson M, Mezrich J, Sollinger HW, et al. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Ann Surg. 2011;253(4):817–25.

    Article  PubMed  PubMed Central  Google Scholar 

  24. •• de Vera ME, et al. Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center. Am J Transplant. 2009;9(4):773–81. DCD results in higher rates of PNF and biliary complications, more likely to result in graft loss compared to DBD donors. However, these increased risk do not appear to influence patient survival outcomes

    Article  PubMed  Google Scholar 

  25. Taner CB, Bulatao IG, Willingham DL, Perry DK, Sibulesky L, Pungpapong S, et al. Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors. Liver Transpl. 2012;18(1):100–11.

    Article  PubMed  Google Scholar 

  26. •• Skaro AI, et al. The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story. Surgery. 2009;146(4):543–52. discussion 552–3. Evaluated the impact of DCD livers on the perioperative and long-term outcomes, suggesting that donor selection of DCD grafts should be implemented to mitigate the increased risk compared to DBD donor grafts

    Article  PubMed  PubMed Central  Google Scholar 

  27. Mateo R, Cho Y, Singh G, Stapfer M, Donovan J, Kahn J, et al. Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data. Am J Transplant. 2006;6(4):791–6.

    Article  CAS  PubMed  Google Scholar 

  28. Lee KW, Simpkins CE, Montgomery RA, Locke JE, Segev DL, Maley WR. Factors affecting graft survival after liver transplantation from donation after cardiac death donors. Transplantation. 2006;82(12):1683–8.

    Article  PubMed  Google Scholar 

  29. Firl DJ, Hashimoto K, O’Rourke C, Diago-Uso T, Fujiki M, Aucejo FN, et al. Impact of donor age in liver transplantation from donation after circulatory death donors: a decade of experience at Cleveland Clinic. Liver Transpl. 2015;21(12):1494–503.

    Article  PubMed  Google Scholar 

  30. Grewal HP, Willingham DL, Nguyen J, Hewitt WR, Taner BC, Cornell D, et al. Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience. Liver Transpl. 2009;15(9):1028–35.

    Article  PubMed  Google Scholar 

  31. Detry O, Meurisse N, Honore P. Impact of donor age in donation after cardiac death liver transplantation: is the cut-off “60” still of relevance? Liver Transpl. 2017;

  32. Mathur AK, Heimbach J, Steffick DE, Sonnenday CJ, Goodrich NP, Merion RM. Donation after cardiac death liver transplantation: predictors of outcome. Am J Transplant. 2010;10(11):2512–9.

    Article  CAS  PubMed  Google Scholar 

  33. Schlegel A, Scalera I, Kalisvaart M, Muiesan P. Impact of donor age in donation after cardiac death liver transplantation: is the cut-off “60” still of relevance? Liver Transpl. 2017;

  34. Kalisvaart M, de Haan JE, Polak WG, Metselaar HJ, Wijnhoven BPL, IJzermans JNM, et al. Comparison of postoperative outcomes between donation after circulatory death and donation after brain death liver transplantation using the comprehensive complication index. Ann Surg. 2017;266(5):772–8.

    Article  PubMed  Google Scholar 

  35. Hong JC, Yersiz H, Kositamongkol P, Xia VW, Kaldas FM, Petrowsky H, et al. Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival. Arch Surg. 2011;146(9):1017–23.

    Article  PubMed  Google Scholar 

  36. Merion RM. Current status and future of liver transplantation. Semin Liver Dis. 2010;30(4):411–21.

    Article  PubMed  Google Scholar 

  37. Parikh ND, Hutton D, Marrero W, Sanghani K, Xu Y, Lavieri M. Projections in donor organs available for liver transplantation in the United States: 2014-2025. Liver Transpl. 2015;21(6):855–63.

    Article  PubMed  Google Scholar 

  38. Noujaim HM, de Ville de Goyet J, Montero EFS, Ribeiro CMF, Capellozzi VL, Crescentini F, et al. Expanding postmortem donor pool using steatotic liver grafts: a new look. Transplantation. 2009;87(6):919–25.

    Article  PubMed  Google Scholar 

  39. Xia W, Ke Q, Wang Y, Feng X, Guo H, Wang W, et al. Donation after cardiac death liver transplantation: graft quality evaluation based on pretransplant liver biopsy. Liver Transpl. 2015;21(6):838–46.

    Article  PubMed  Google Scholar 

  40. Fishbein TM, Fiel MI, Emre S, Cubukcu O, Guy SR, Schwartz ME, et al. Use of livers with microvesicular fat safely expands the donor pool. Transplantation. 1997;64(2):248–51.

    Article  CAS  PubMed  Google Scholar 

  41. Deroose JP, Kazemier G, Zondervan P, IJzermans JNM, Metselaar HJ, Alwayn IPJ. Hepatic steatosis is not always a contraindication for cadaveric liver transplantation. HPB (Oxford). 2011;13(6):417–25.

    Article  Google Scholar 

  42. Sainz-Barriga M, Reyntjens K, Costa MG, Scudeller L, Rogiers X, Wouters P, et al. Prospective evaluation of intraoperative hemodynamics in liver transplantation with whole, partial and DCD grafts. Am J Transplant. 2010;10(8):1850–60.

    Article  CAS  PubMed  Google Scholar 

  43. Wong TC, et al. Excellent outcomes of liver transplantation using severely steatotic grafts from brain-dead donors. Liver Transpl. 2016;22(2):226–36.

    Article  PubMed  Google Scholar 

  44. Posner AD, et al. Resolution of donor non-alcoholic fatty liver disease following liver transplantation. Clin Transpl. 2017;31(9)

  45. Reich DJ, Mulligan DC, Abt PL, Pruett TL, Abecassis MMI, D’Alessandro A, et al. ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant. 2009;9(9):2004–11.

    Article  CAS  PubMed  Google Scholar 

  46. Bernat JL, D’Alessandro AM, Port FK, Bleck TP, Heard SO, Medina J, et al. Report of a National Conference on donation after cardiac death. Am J Transplant. 2006;6(2):281–91.

    Article  CAS  PubMed  Google Scholar 

  47. Thuret R, et al. Ischemic pre- and post-conditioning: current clinical applications. Prog Urol. 2014;24(Suppl 1):S56–61.

    Article  PubMed  Google Scholar 

  48. Reich DJ, Guy SR. Donation after cardiac death in abdominal organ transplantation. Mt Sinai J Med. 2012;79(3):365–75.

    Article  PubMed  Google Scholar 

  49. Busuttil RW, Klintmalm GB. Transplantation of the liver. 2nd ed. Philadelphia: Elsevier Saunders; 2005. xxx, 1485 p

    Google Scholar 

  50. Casavilla A, Ramirez C, Shapiro R, Nghiem D, Miracle K, Bronsther O, et al. Experience with liver and kidney allografts from non-heart-beating donors. Transplantation. 1995;59(2):197–203.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Casavilla A, Ramirez C, Shapiro R, Nghiem D, Miracle K, Fung JJ, et al. Liver and kidney transplantation from non-heart beating donors: the Pittsburgh experience. Transplant Proc. 1995;27(1):710–2.

    CAS  PubMed  PubMed Central  Google Scholar 

  52. Dodson F, Pinna A, Jabbour N, Casavilla A, Khan F, Corry R. Advantages of the rapid en bloc technique for pancreas/liver recovery. Transplant Proc. 1995;27(6):3050.

    CAS  PubMed  Google Scholar 

  53. Adam R, Cailliez V, Majno P, Karam V, McMaster P, Calne RY, et al. Normalised intrinsic mortality risk in liver transplantation: European liver transplant registry study. Lancet. 2000;356(9230):621–7.

    Article  CAS  PubMed  Google Scholar 

  54. Routh D, Naidu S, Sharma S, Ranjan P, Godara R. Changing pattern of donor selection criteria in deceased donor liver transplant: a review of literature. J Clin Exp Hepatol. 2013;3(4):337–46.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Mourad MM, Algarni A, Liossis C, Bramhall SR. Aetiology and risk factors of ischaemic cholangiopathy after liver transplantation. World J Gastroenterol. 2014;20(20):6159–69.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Eren EA, Latchana N, Beal E, Hayes D Jr, Whitson B, Black SM. Donations after circulatory death in liver transplant. Exp Clin Transplant. 2016;14(5):463–70.

    PubMed  PubMed Central  Google Scholar 

  57. Nemes B, Gámán G, Polak WG, Gelley F, Hara T, Ono S, et al. Extended criteria donors in liver transplantation. Part I: reviewing the impact of determining factors. Expert Rev Gastroenterol Hepatol. 2016;10(7):827–39.

    Article  CAS  PubMed  Google Scholar 

  58. Nemes B, Gámán G, Polak WG, Gelley F, Hara T, Ono S, et al. Extended-criteria donors in liver transplantation part II: reviewing the impact of extended-criteria donors on the complications and outcomes of liver transplantation. Expert Rev Gastroenterol Hepatol. 2016;10(7):841–59.

    Article  CAS  PubMed  Google Scholar 

  59. •• Coffey JC, et al. The influence of functional warm ischemia time on DCD liver transplant recipients’ outcomes. Clin Transplant. 2017;31(10) Authours suggest and describe functional warm ischemia time parameters, as important predictors of ischemic cholangiopathy following DCD donor liver transplant

  60. Cao Y, Shahrestani S, Chew HC, Crawford M, Macdonald PS, Laurence J, et al. Donation after circulatory death for liver transplantation: a meta-analysis on the location of life support withdrawal affecting outcomes. Transplantation. 2016;100(7):1513–24.

    Article  CAS  PubMed  Google Scholar 

  61. Lema Zuluaga GL, Serna Agudelo RE, Zuleta Tobon JJ. Preservation solutions for liver transplantation in adults: celsior versus custodiol: a systematic review and meta-analysis with an indirect comparison of randomized trials. Transplant Proc. 2013;45(1):25–32.

    Article  CAS  PubMed  Google Scholar 

  62. Adam R, Cailliez V, Karam V. Evaluation of HTK preservation solutions in liver transplantation: a long-term propensity-based analysis of outcome from the European liver transplant registry. Am J Transplant. 2017;17(2):585–6.

    Article  CAS  PubMed  Google Scholar 

  63. Meine MH, Leipnitz I, Zanotelli ML, Schlindwein ES, Kiss G, Martini J, et al. Comparison between IGL-1 and HTK preservation solutions in deceased donor liver transplantation. Transplant Proc. 2015;47(4):888–93.

    Article  CAS  PubMed  Google Scholar 

  64. Gulsen MT, Girotra M, Cengiz-Seval G, Price J, Singh VK, Segev DL, et al. HTK preservative solution is associated with increased biliary complications among patients receiving DCD liver transplants: a single center experience. Ann Transplant. 2013;18:69–75.

    Article  CAS  PubMed  Google Scholar 

  65. Brunner SM, Junger H, Ruemmele P, Schnitzbauer AA, Doenecke A, Kirchner GI, et al. Bile duct damage after cold storage of deceased donor livers predicts biliary complications after liver transplantation. J Hepatol. 2013;58(6):1133–9.

    Article  PubMed  Google Scholar 

  66. Khorsandi SE, Giorgakis E, Vilca-Melendez H, O’Grady J, Heneghan M, Aluvihare V, et al. Developing a donation after cardiac death risk index for adult and pediatric liver transplantation. World J Transplant. 2017;7(3):203–12.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Doyle MB, et al. Outcomes using grafts from donors after cardiac death. J Am Coll Surg. 2015;221(1):142–52.

    Article  PubMed  Google Scholar 

  68. Terblanche J, Koep LJ, Starzl TE. Liver transplantation. Med Clin North Am. 1979;63(3):507–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Seal JB, Bohorquez H, Reichman T, Kressel A, Ghanekar A, Cohen A, et al. Thrombolytic protocol minimizes ischemic-type biliary complications in liver transplantation from donation after circulatory death donors. Liver Transpl. 2015;21(3):321–8.

    Article  PubMed  Google Scholar 

  70. Kubal C, et al. Optimization of perioperative conditions to prevent ischemic cholangiopathy in donation after circulatory death donor liver transplantation. Transplantation. 2016;100(8):1699–704.

    Article  CAS  PubMed  Google Scholar 

  71. Chirichella TJ, Dunham CM, Zimmerman MA, Phelan EM, Mandell MS, Conzen KD, et al. Donor preoperative oxygen delivery and post-extubation hypoxia impact donation after circulatory death hypoxic cholangiopathy. World J Gastroenterol. 2016;22(12):3392–403.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. O’Neill S, Roebuck A, Khoo E, Wigmore SJ, Harrison EM. A meta-analysis and meta-regression of outcomes including biliary complications in donation after cardiac death liver transplantation. Transpl Int. 2014;27(11):1159–74.

    Article  PubMed  Google Scholar 

  73. Giorgakis E, et al. Minimization of ischemic cholangiopathy in donation after cardiac death liver transplantation: is it thrombolytic therapy or warm ischemic time stringency and donor bile duct flush? Am J Transplant. 2017;

  74. Gilbo N, Catalano G, Salizzoni M, Romagnoli R. Liver graft preconditioning, preservation and reconditioning. Dig Liver Dis. 2016;48(11):1265–74.

    Article  PubMed  Google Scholar 

  75. Koneru B, Shareef A, Dikdan G, Desai K, Klein KM, Peng B, et al. The ischemic preconditioning paradox in deceased donor liver transplantation-evidence from a prospective randomized single blind clinical trial. Am J Transplant. 2007;7(12):2788–96.

    Article  CAS  PubMed  Google Scholar 

  76. Azoulay D, del Gaudio M, Andreani P, Ichai P, Sebag M??, Adam R??, et al. Effects of 10 minutes of ischemic preconditioning of the cadaveric liver on the graft’s preservation and function: the ying and the yang. Ann Surg. 2005;242(1):133–9.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Azoulay D, Lucidi V, Andreani P, Maggi U, Sebagh M, Ichai P, et al. Ischemic preconditioning for major liver resection under vascular exclusion of the liver preserving the caval flow: a randomized prospective study. J Am Coll Surg. 2006;202(2):203–11.

    Article  PubMed  Google Scholar 

  78. Franchello A, Gilbo N, David E, Ricchiuti A, Romagnoli R, Cerutti E, et al. Ischemic preconditioning (IP) of the liver as a safe and protective technique against ischemia/reperfusion injury (IRI). Am J Transplant. 2009;9(7):1629–39.

    Article  CAS  PubMed  Google Scholar 

  79. Gurusamy KS, et al. Ischaemic preconditioning for liver transplantation. Cochrane Database Syst Rev. 2008;(1):CD006315.

  80. Kristo I, Wilflingseder J, Kainz A, Marschalek J, Wekerle T, Mühlbacher F, et al. Effect of intraportal infusion of tacrolimus on ischaemic reperfusion injury in orthotopic liver transplantation: a randomized controlled trial. Transpl Int. 2011;24(9):912–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Beck-Schimmer B, Bonvini JM, Schadde E, Dutkowski P, Oberkofler CE, Lesurtel M, et al. Conditioning with sevoflurane in liver transplantation: results of a multicenter randomized controlled trial. Transplantation. 2015;99(8):1606–12.

    Article  CAS  PubMed  Google Scholar 

  82. Monbaliu D, Vekemans K, Hoekstra H, Vaahtera L, Libbrecht L, Derveaux K, et al. Multifactorial biological modulation of warm ischemia reperfusion injury in liver transplantation from non-heart-beating donors eliminates primary nonfunction and reduces bile salt toxicity. Ann Surg. 2009;250(5):808–17.

    Article  PubMed  Google Scholar 

  83. Hashimoto K, Eghtesad B, Gunasekaran G, Fujiki M, Uso TD, Quintini C, et al. Use of tissue plasminogen activator in liver transplantation from donation after cardiac death donors. Am J Transplant. 2010;10(12):2665–72.

    Article  CAS  PubMed  Google Scholar 

  84. Tolba RH, Yonezawa K, Song S, Burger C, Minor T. Synergistic value of fibrinolysis and hypothermic aerobic preservation with oxygen in the protection of livers from non-heart-beating donors: an experimental model. Transplant Proc. 2004;36(10):2927–30.

    Article  CAS  PubMed  Google Scholar 

  85. Lang R, He Q, Jin ZK, Han DD, Chen DZ. Urokinase perfusion prevents intrahepatic ischemic-type biliary lesion in donor livers. World J Gastroenterol. 2009;15(28):3538–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Monbaliu D, Pirenne J, Talbot D. Liver transplantation using donation after cardiac death donors. J Hepatol. 2012;56(2):474–85.

    Article  PubMed  Google Scholar 

  87. Noormohamed MS, Kanwar A, Ray C, Wright MC, Cowie DE, Stamp S, et al. Extracorporeal membrane oxygenation for resuscitation of deceased cardiac donor livers for hepatocyte isolation. J Surg Res. 2013;183(2):e39–48.

    Article  PubMed  Google Scholar 

  88. Goussous N, et al. ECMO in liver transplant. Am J Transplant. 2017;

  89. Guarrera JV, Henry SD, Samstein B, Odeh-Ramadan R, Kinkhabwala M, Goldstein MJ, et al. Hypothermic machine preservation in human liver transplantation: the first clinical series. Am J Transplant. 2010;10(2):372–81.

    Article  CAS  PubMed  Google Scholar 

  90. •• Guarrera JV, et al. Hypothermic machine preservation facilitates successful transplantation of “orphan” extended criteria donor livers. Am J Transplant. 2015;15(1):161–9. Suggests that extended criteria donor outcomes may be imporved with HMP, reducing the risk of ischemic cholangiopahty and graft loss

    Article  CAS  PubMed  Google Scholar 

  91. Dutkowski P, Schlegel A, de Oliveira M, Müllhaupt B, Neff F, Clavien PA. HOPE for human liver grafts obtained from donors after cardiac death. J Hepatol. 2014;60(4):765–72.

    Article  PubMed  Google Scholar 

  92. Op den Dries S, Karimian N, Porte RJ. Normothermic machine perfusion of discarded liver grafts. Am J Transplant. 2013;13(9):2504.

    Article  Google Scholar 

  93. Sutton ME, op den Dries S, Karimian N, Weeder PD, de Boer MT, Wiersema-Buist J, et al. Criteria for viability assessment of discarded human donor livers during ex vivo normothermic machine perfusion. PLoS One. 2014;9(11):e110642.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Ravikumar R, Jassem W, Mergental H, Heaton N, Mirza D, Perera MTPR, et al. Liver transplantation after ex vivo Normothermic machine preservation: a phase 1 (first-in-man) clinical trial. Am J Transplant. 2016;16(6):1779–87.

    Article  CAS  PubMed  Google Scholar 

  95. Angelico R, Perera MTPR, Ravikumar R, Holroyd D, Coussios C, Mergental H, et al. Normothermic machine perfusion of deceased donor liver grafts is associated with improved postreperfusion hemodynamics. Transplant Direct. 2016;2(9):e97.

    Article  PubMed  PubMed Central  Google Scholar 

  96. Bral M, Gala-Lopez B, Bigam D, Kneteman N, Malcolm A, Livingstone S, et al. Preliminary single-center Canadian experience of human normothermic ex vivo liver perfusion: results of a clinical trial. Am J Transplant. 2017;17(4):1071–80.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anton Skaro.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Liver Transplantation

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sharma, H., Tun Abraham, M., Lozano, P. et al. DCD Liver Transplant: a Meta-review of the Evidence and Current Optimization Strategies. Curr Transpl Rep 5, 153–165 (2018). https://doi.org/10.1007/s40472-018-0193-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40472-018-0193-x

Keywords

Navigation